Teladoc Health (NYSE:TDOC) Receives "Hold" Rating from Needham & Company LLC

Teladoc Health (NYSE:TDOC - Get Free Report)'s stock had its "hold" rating reaffirmed by Needham & Company LLC in a report released on Thursday,Benzinga reports.

Other equities research analysts have also issued research reports about the stock. Piper Sandler cut their target price on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a research note on Thursday, February 27th. Bank of America cut their price objective on Teladoc Health from $9.50 to $8.00 and set a "neutral" rating on the stock in a research report on Friday, April 11th. The Goldman Sachs Group decreased their target price on Teladoc Health from $16.00 to $13.00 and set a "buy" rating for the company in a research report on Monday, March 3rd. Royal Bank of Canada lifted their price target on Teladoc Health from $11.00 to $12.00 and gave the company an "outperform" rating in a research report on Friday, January 24th. Finally, Citigroup decreased their price objective on Teladoc Health from $11.00 to $8.75 and set a "neutral" rating for the company in a report on Friday, April 25th. Eleven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $10.46.

Teladoc Health Stock Down 2.3 %

Shares of NYSE:TDOC opened at $7.16 on Thursday. The stock's 50-day moving average is $8.19 and its 200 day moving average is $9.52. The company has a market cap of $1.25 billion, a PE ratio of -1.24 and a beta of 1.73. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. Teladoc Health has a 1 year low of $6.35 and a 1 year high of $15.21.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The business had revenue of $640.49 million for the quarter, compared to analysts' expectations of $639.44 million. Sell-side analysts anticipate that Teladoc Health will post -1.16 EPS for the current year.

Insider Transactions at Teladoc Health

In other news, insider Adam C. Vandervoort sold 11,011 shares of Teladoc Health stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the transaction, the insider now owns 64,308 shares in the company, valued at $541,473.36. This trade represents a 14.62 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 0.58% of the company's stock.

Hedge Funds Weigh In On Teladoc Health

Institutional investors and hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. raised its stake in shares of Teladoc Health by 5.9% in the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider's stock worth $167,830,000 after buying an additional 1,029,829 shares during the period. Point72 Asset Management L.P. raised its stake in Teladoc Health by 33.6% during the 4th quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider's stock worth $101,625,000 after acquiring an additional 2,813,568 shares during the period. Renaissance Technologies LLC raised its stake in Teladoc Health by 15.5% during the 4th quarter. Renaissance Technologies LLC now owns 5,674,542 shares of the health services provider's stock worth $51,582,000 after acquiring an additional 763,265 shares during the period. Geode Capital Management LLC lifted its holdings in Teladoc Health by 0.6% during the fourth quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider's stock valued at $35,894,000 after purchasing an additional 22,664 shares in the last quarter. Finally, Maple Rock Capital Partners Inc. boosted its position in shares of Teladoc Health by 189.5% in the fourth quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock worth $32,369,000 after purchasing an additional 2,331,000 shares during the period. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.